The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Cyclic Peptides as Therapeutic Agents and Biochemical Tools
Open accessAbstract
There are many cyclic peptides with diverse biological activities, such as antibacterial activity, immunosuppressive activity, and anti-tumor activity, and so on. Encouraged by natural cyclic peptides with biological activity, efforts have been made to develop cyclic peptides with both genetic and synthetic methods. The genetic methods include phage display, intein-based cyclic peptides, and mRNA display. The synthetic methods involve individual synthesis, parallel synthesis, as well as split-and-pool synthesis. Recent development of cyclic peptide library based on split-and-pool synthesis allows on-bead screening, in-solution screening, and microarray screening of cyclic peptides for biological activity. Cyclic peptides will be useful as receptor agonist/antagonist, RNA binding molecule, enzyme inhibitor and so on, and more cyclic peptides will emerge as therapeutic agents and biochemical tools.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Smith, G. P. (1985) · Science · doi:10.1126/science.4001944 · Cited by 4,143
A new type of synthetic peptide library for identifying ligand-binding activity
Lam, K. S., Salmon, S. E., Hersh, E. M., Hruby, V. J., Kazmierski, W. M., & Knapp, R. J. (1991) · Nature · doi:10.1038/354082a0 · Cited by 1,802
Synthetic therapeutic peptides: science and market
Vlieghe, P., Lisowski, V., Martinez, J., & Khrestchatisky, M. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2009.10.009 · Cited by 1,476
Houghten, R. A., Pinilla, C., Blondelle, S. E., Appel, J. R., Dooley, C. T., & Cuervo, J. H. (1991) · Nature · doi:10.1038/354084a0 · Cited by 1,326
General method for rapid synthesis of multicomponent peptide mixtures
FURKA, Á., SEBESTYÉN, F., ASGEDOM, M., & DIBÓ, G. (1991) · International Journal of Peptide and Protein Research · doi:10.1111/j.1399-3011.1991.tb00765.x · Cited by 1,155
RNA-peptide fusions for the in vitro selection of peptides and proteins
Roberts, R. W., & Szostak, J. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12297 · Cited by 1,105
Matsuzaki, K. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00197-2 · Cited by 1,010
Mas-Moruno, C., Rechenmacher, F., & Kessler, H. (2010) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152010794728639 · Cited by 647
A Synthetic Peptide from Fibronectin Inhibits Experimental Metastasis of Murine Melanoma Cells
Humphries, M. J., Olden, K., & Yamada, K. M. (1986) · Science · doi:10.1126/science.3726541 · Cited by 626
Rezai, T., Yu, B., Millhauser, G. L., Jacobson, M. P., & Lokey, R. S. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0563455 · Cited by 490
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
Murphy, E. A., Majeti, B. K., Barnes, L. A., Makale, M., Weis, S. M., Lutu-Fuga, K., Wrasidlo, W., & Cheresh, D. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803728105 · Cited by 455
Production of cyclic peptides and proteins in vivo
Scott, C. P., Abel-Santos, E., Wall, M., Wahnon, D. C., & Benkovic, S. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13638 · Cited by 402
Selection of peptides binding to the alpha 5 beta 1 integrin from phage display library.
Koivunen, E., Gay, D. A., & Ruoslahti, E. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80715-7 · Cited by 344 · cited 1×
“However, cyclic peptides formed from disulfide bond formation were sometimes obtained from phage display as exampled by RGD peptide (Koivunen et al., 1993) (Fig.”
BackgroundConformation/activity studies of rationally designed potent anti‐adhesive RGD peptides
GURRATH, M., MÜLLER, G., KESSLER, H., AUMAILLEY, M., & TIMPL, R. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb17495.x · Cited by 317
Tamamura, H., Xu, Y., Hattori, T., Zhang, X., Arakaki, R., Kanbara, K., Omagari, A., Otaka, A., Ibuka, T., Yamamoto, N., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9871 · Cited by 308
Gehlsen, K. R. (1988) · The Journal of Cell Biology · doi:10.1083/jcb.106.3.925 · Cited by 303
Biomimetic synthesis and optimization of cyclic peptide antibiotics
Kohli, R. M., Walsh, C. T., & Burkart, M. D. (2002) · Nature · doi:10.1038/nature00907 · Cited by 287
O'Neil, K. T., Hoess, R. H., Jackson, S. A., Ramachandran, N. S., Mousa, S. A., & DeGrado, W. F. (1992) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340140411 · Cited by 278
Park, B.-W., Zhang, H.-T., Wu, C., Berezov, A., Zhang, X., Dua, R., Wang, Q., Kao, G., O'Rourke, D. M., Greene, M. I., et al. (2000) · Nature Biotechnology · doi:10.1038/72651 · Cited by 199
Calder, A. G., Garden, K. E., Anderson, S. E., & Lobley, G. E. (1999) · Rapid Communications in Mass Spectrometry · doi:10.1002/(sici)1097-0231(19991115)13:21<2174::aid-rcm771>3.0.co;2-k · Cited by 184
Peptides as Drugs: Is There a Market?
Loffet, A. (2002) · Journal of Peptide Science · doi:10.1002/psc.366 · Cited by 170
Wenger, R. M. (1984) · Helvetica Chimica Acta · doi:10.1002/hlca.19840670220 · Cited by 163
Tavassoli, A., Lu, Q., Gam, J., Pan, H., Benkovic, S. J., & Cohen, S. N. (2008) · ACS Chemical Biology · doi:10.1021/cb800193n · Cited by 153
Design of Cyclic Peptides That Bind Protein Surfaces with Antibody-Like Affinity
Millward, S. W., Fiacco, S. V., Austin, R. J., & Roberts, R. W. (2007) · ACS Chemical Biology · doi:10.1021/cb7001126 · Cited by 137
Quantitative Comparison of the Relative Cell Permeability of Cyclic and Linear Peptides
Kwon, Y.-U., & Kodadek, T. J. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.05.006 · Cited by 126
Joo, S. H., Xiao, Q., Ling, Y. L., Gopishetty, B., & Pei, D. (2006) · Journal of the American Chemical Society · doi:10.1021/ja063722k · Cited by 120
Self-citationA systematic method for identifying small-molecule modulators of protein–protein interactions
Horswill, A. R., Savinov, S. N., & Benkovic, S. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406999101 · Cited by 110 · cited 1×
“This method was used to screen for the inhibitors of protein-protein interactions (Horswill et al., 2004; Tavassoli and Benkovic, 2005; Tavassoli et al., 2008).”
MethodGenetically Selected Cyclic‐Peptide Inhibitors of AICAR Transformylase Homodimerization
Tavassoli, A., & Benkovic, S. J. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200500417 · Cited by 105
Exploring privileged structures: the combinatorial synthesis of cyclic peptides
Horton, D. A., Bourne, G. T., & Smythe, M. L. (2002) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1020863921840 · Cited by 102
Athanassiou, Z., Dias, R. L. A., Moehle, K., Dobson, N., Varani, G., & Robinson, J. A. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0497680 · Cited by 96
STUDIES ON A BACTERICIDAL AGENT EXTRACTED FROM A SOIL BACILLUS
Dubos, R. J., & Cattaneo, C. I. (1939) · The Journal of Experimental Medicine · doi:10.1084/jem.70.3.249 · Cited by 91
Membrane Permeable Cyclic Peptidyl Inhibitors against Human Peptidylprolyl Isomerase Pin1
Liu, T., Liu, Y., Kao, H., & Pei, D. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901778v · Cited by 84
Lalonde, M. S., Lobritz, M. A., Ratcliff, A. N., Chamanian, M., Athanassiou, Z., Tyagi, M., Wong, J. Y., Robinson, J. A., Karn, J., Varani, G., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002038 · Cited by 76
Athanassiou, Z., Patora‐Komisarska, K., Dias, R. L. A., Moehle, K., Robinson, J. A., & Varani, G. (2006) · Biochemistry · doi:10.1021/bi0619371 · Cited by 75
‘Gramicidin S’: over-all chemical characteristics and amino-acid composition
Synge, R. L. M. (1945) · Biochemical Journal · doi:10.1042/bj0390363 · Cited by 73
Translating peptides into small molecules
Hummel, G., Reineke, U., & Reimer, U. (2006) · Molecular BioSystems · doi:10.1039/b611791k · Cited by 70
Protein Splicing Mechanisms and Applications
Perler, F. B. (2005) · IUBMB Life · doi:10.1080/15216540500163343 · Cited by 70
Protein splicing mechanisms and applications
Perler, F. B. (2006) · IUBMB Life · doi:10.1080/15216540500531739 · Cited by 66
High-Throughput Synthesis and Screening of Cyclic Peptide Antibiotics
Xiao, Q., & Pei, D. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070282e · Cited by 58
Liu, T., Joo, S. H., Voorhees, J. L., Brooks, C. L., & Pei, D. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.01.015 · Cited by 57
Self-citationCyclic peptide inhibitors of HIV-1 integrase derived from the LEDGF/p75 protein
Hayouka, Z., Hurevich, M., Levin, A., Benyamini, H., Iosub‐Amir, A., Maes, M., Shalev, D. E., Loyter, A., Gilon, C., & Friedler, A. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.09.046 · Cited by 53
Genetic Selection of Cyclic Peptide Dam Methyltransferase Inhibitors
Naumann, T. A., Tavassoli, A., & Benkovic, S. J. (2007) · ChemBioChem · doi:10.1002/cbic.200700561 · Cited by 50
Optimization of a Cyclic Peptide Inhibitor of Ser/Thr Phosphatase PPM1D (Wip1)
Hayashi, R., Tanoue, K., Durell, S. R., Chatterjee, D. K., Jenkins, L. M. M., Appella, D. H., & Appella, E. (2011) · Biochemistry · doi:10.1021/bi101949t · Cited by 47
Encoded combinatorial libraries for the construction of cyclic peptoid microarrays
Kwon, Y.-U., & Kodadek, T. J. (2008) · Chemical Communications · doi:10.1039/b812735b · Cited by 44
Siegel, M. M., Huang, J., Lin, B., Tsao, R., & Edmonds, C. G. (1994) · Journal of Mass Spectrometry · doi:10.1002/bms.1200230403 · Cited by 41
Sweeney, M. C., & Pei, D. (2003) · Journal of Combinatorial Chemistry · doi:10.1021/cc020113+ · Cited by 39
Stauch, B., Simon, B., Basile, T., Schneider, G., Malek, N. P., Kalesse, M., & Carlomagno, T. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000140 · Cited by 32
Cited by
LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor
Ge, X., Yang, H., Bednarek, M. A., Galon-Tilleman, H., Chen, P., Chen, M., Lichtman, J. S., Wang, Y., Dalmas, O., Yin, Y., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.10.016 · Cited by 376
“Although the bicyclic structure of LEAP2 is reminiscent of many peptide hormones (Joo, 2012), the biological function of LEAP2 is not well understood.”
BackgroundAntimicrobial peptides towards clinical application: Delivery and formulation
Wang, C., Hong, T., Cui, P., Wang, J., & Xia, J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.028 · Cited by 281
Protease-Resistant Peptides for Targeting and Intracellular Delivery of Therapeutics
Lucana, M. C., Arruga, Y., Petrachi, E., Roig, A., Lucchi, R., & Oller-Salvia, B. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122065 · Cited by 102
Ynamide‐Mediated Peptide Bond Formation: Mechanistic Study and Synthetic Applications
Xu, S., Jiang, D., Peng, Z., Hu, L., Liu, T., Zhao, L., & Zhao, J. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202212247 · Cited by 46
Mull, R. W., Harrington, A., Sanchez, L. A., & Tal-Gan, Y. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666180518090705 · Cited by 41
Metadata
- Authors
- Joo, S.-H.
- Venue
- Biomolecules and Therapeutics
- Published
- 2012-01-31
- Volume
- 20
- Issue
- 1
- Pages
- 19-26
- ISSN
- 1976-9148 (ISSN-L)
- OpenAlex
- W2101187401
- Cited by
- 359
- References
- 48
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.